Guidelines for Safe and Effective Use of Hydroxychloroquine in COVID-19 Patients


Guidelines for Safe and Effective Use of Hydroxychloroquine in COVID-19 Patients


Hannah Ariel

Department of Chemistry and Biochemistry, Queens College


 International Journal of Hospital Pharmacy

The emergent need to treat COVID-19 patient must be tempered with safe use of drugs. The guideline set forth provides parameters for dosing and monitoring hydroxychloroquine in this population, reducing the occurrence of adverse effects and improving overall pharmacotherapy.


Keywords: Hydroxychloroquine, COVID-19 Patients, Safe and Effective Use

Free Full-text PDF


How to cite this article:
Hannah Ariel. Guidelines for Safe and Effective Use of Hydroxychloroquine in COVID-19 Patients. International Journal of Hospital Pharmacy, 2020, 5:38. DOI: 10.28933/ijhp-2020-05-1205


References:

1. Hashem AM, Alghamdi BS, Algaissi AA, et l. Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections. A narrative review. Travel Med Infect Dis 2020: May 6 doi./j.tmaid.2020.101735
2. Cooke-Ariel H. Chronotherapeutic applications in cardiovascular diseases. Cardiology Today. February 2009.
3. Liu, D, Zhang Y, Sum-Wing Kwong, J et l. Chloroquine and hydroxychloroquine are associated with reduced cardiovascular risk: a systematic review and meta-analysis. Drug Des Devel Ther 2018 Jun 11(12): 1685-1695 doi: 10.2147/DDDT.S166893.